PSMA-RADS 2.0: a revised framework for PSMA-targeted imaging interpretation and clinical decision-making.
1/5 보강
PSMA-RADS version 1, introduced by Rowe et al.
APA
Elsamny A, Wardeh A, et al. (2026). PSMA-RADS 2.0: a revised framework for PSMA-targeted imaging interpretation and clinical decision-making.. Abdominal radiology (New York), 51(1), 180-192. https://doi.org/10.1007/s00261-025-05068-7
MLA
Elsamny A, et al.. "PSMA-RADS 2.0: a revised framework for PSMA-targeted imaging interpretation and clinical decision-making.." Abdominal radiology (New York), vol. 51, no. 1, 2026, pp. 180-192.
PMID
40514459 ↗
Abstract 한글 요약
PSMA-RADS version 1, introduced by Rowe et al. in 2017, provides a framework for classifying PSMA-targeted PET scans and individual findings based on their likelihood of representing prostate cancer. The system was optimized for findings outside the prostate and was structured as a five-point scale (Rowe et al., Eur Urol 73:485-487, 2018. https://doi.org/10.1016/j.eururo.2017.10.027 . In 2022, an updated PSMA-RADS version was proposed to refine category definitions, address limitations of the initial version, and enhance its role in guiding clinical decisions. The framework includes both lesion-level and patient-level classifications, offering confidence and probability scores in support of clinical decision-making (Leung et al., EJNMMI Res. https://doi.org/10.1186/S13550-022-00948-1 ). This article aims to explore the changes introduced in the updated scale and evaluate their impact on clinical management. It is intended to inform abdominal and general radiologists about recent developments in PSMA-targeted imaging to support multidisciplinary collaboration and patient care.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Prostatic Neoplasms
- Male
- Glutamate Carboxypeptidase II
- Clinical Decision-Making
- Antigens
- Surface
- Positron Emission Tomography Computed Tomography
- Positron-Emission Tomography
- Radiology Information Systems
- PSMA RADS
- PSMA PET/CT
- SUV threshold
- biochemical recurrence
- miPSMA score
- treatment response evaluation
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.